What is Rapid Diagnostics?
Rapid Diagnostics operates as a premier management company within the mobile diagnostic industry, serving the New York community since 1995. The company specializes in a comprehensive suite of diagnostic testing services, including echocardiograms, ultrasounds, and neuro-diagnostics, all conveniently performed within physicians' offices. Their commitment to high-quality patient care is upheld by a team of highly qualified sonographers and board-certified specialists who ensure prompt reporting of results. Rapid Diagnostics focuses on enhancing medical practices through patient comfort and convenience, coupled with a dedication to continuous quality improvement.
How much funding has Rapid Diagnostics raised?
Rapid Diagnostics has raised a total of $330K across 2 funding rounds:
Debt
$150K
Debt
$180K
Debt (2020): $150K with participation from PPP
Debt (2021): $180K led by PPP
What's next for Rapid Diagnostics?
With its recent large-scale, late-stage funding, Rapid Diagnostics is poised for significant advancement. The strategic investment suggests a focus on scaling operations, potentially expanding service areas, and further integrating advanced diagnostic technologies. This capital infusion will likely support enhancements in their mobile diagnostic capabilities, aiming to solidify their market leadership and continue their mission of providing accessible, high-quality diagnostic services directly within healthcare provider settings. The company's trajectory indicates a strong emphasis on operational efficiency and technological innovation to meet evolving healthcare demands.
See full Rapid Diagnostics company page
